Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: A randomised controlled trial

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 99, Issue 2, 2014, Pages

  Oncel, Mehmet Yekta ^a   Sari, Fatma Nur ^a   Arayici, Sema ^a   Guzoglu, Nilufer ^a   Erdeve, Omer ^b   Uras, Nurdan ^a   Oguz, Serife Suna ^a   Dilmen, Ugur ^a,c  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FEEDING INTOLERANCE; LACTOBACILLUS REUTERI; NECROTIZING ENTEROCOLITIS; PRETERM INFANT;

ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; LACTOBACILLUS REUTERI; LENGTH OF STAY; MALE; PROBIOTICS; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84894038594     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304745     Document Type: Article

References (25)

1. Simpson CD, Ye XY, Hellmann J, et al. Trends in cause-specific mortality at a Canadian outborn NICU. Pediatrics 2010;126:e1538-44.
2. Berrington JE, Hearn RI, Bythell M, et al. Deaths in preterm infants: changing pathology over 2 decades. J Pediatr 2012;160:49-53.
3. Stoll BJ, Hansen NI, Bell EF. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443-56.
4. Sharma R, Hudak ML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol 2013;40:27-51.
5. Alfaleh K, Anabress J, Bassler D, et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011;(3):CD0055496.
6. Millar M, Wilks M, Costeloe K. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed 2003;88:F354-8. (Pubitemid 37094250)
7. Orrhage K, Nord CE. Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl 1999;88:47-57. (Pubitemid 29489143)
8. Mattar AF, Drongowski RA, Coran AG, et al. Effect of probiotics on enterocyte bacterial translocation in vitro. Pediatr Surg Int 2001;17:265-8. (Pubitemid 32487929)
9. Reid G, Howard J, Gan BS. Can bacterial interference prevent infection? Trends Microbiol 2001;9:424-8. (Pubitemid 32844328)
10. Duffy LC. Interactions mediating bacterial translocation in the immature intestine. J Nutr 2000;130:432-6.
11. Link-Amster H, Rochat F, Saudan KY, et al. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994;10:55-63. (Pubitemid 24355531)
12. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6. (Pubitemid 41207832)
13. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008;122:693-700.
14. Sari FN, Dizdar EA, Oguz S, et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011;65:434-9.
15. Shornikova A, Casas I, MykkAnen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis 1997;16:1103-7. (Pubitemid 28006664)
16. Valeur N, Engel P, Carbajal N, et al. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004;70:1176-81. (Pubitemid 38568246)
17. Miyoshi Y, Okada S, Uchimura T, et al. A mucus adhesion promoting protein, MapA, mediates the adhesion of Lactobacillus reuteri to Caco-2 human intestinal epithelial cells. Biosci Biotechnol Biochem 2006;70:1622-8. (Pubitemid 44124920)
18. Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: a practitioner's perspective. Pediatr Rev 1988;9:219-26.
19. Isolauri E. Immune effects of probiotics. In: Hanson LA, Yorken RH. eds. Probiotics, Other Nutritional Factors, and Intestinal Microflora. Nestle Nutrition Workshop Series. Philadelphia: Vevey/Lippincott-Raven, 1999:229-41.
20. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8.
21. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013;98:F5-9.
22. Rojas MA, Lozano JM, Rojas MX, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012;130:e1113-20.
23. Gupta V, Garg R. Probiotics. Indian J Med Microbiol 2009;27:202-9.
24. Al-Hosni M, Duenas M, Hawk M, et al. Probiotics supplemented feeding in extremely low-birth-weight infants. J Perinatol 2012;32:253-9.
25. Hunter C, Dimaguila MA, Gal P, et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight <1000 grams: a sequential analysis. BMC Pediatr 2012;12:142.